These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9337014)

  • 1. Reduced prevalence of onchocerciasis following mass treatment with ivermectin.
    Oyibo WA; Fagbenro-Beyioku AF
    East Afr Med J; 1997 May; 74(5):326-30. PubMed ID: 9337014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of repeated community-based ivermectin treatment on the intensity of onchocerciasis in Nigeria.
    Oyibo WA; Fagbenro-Beyioku AF
    Rural Remote Health; 2003; 3(2):211. PubMed ID: 15877511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
    Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria.
    Sam-Wobo SO; Adeleke MA; Jayeola OA; Adeyi AO; Oluwole AS; Ikenga M; Lawniye F; Gazama J; Kagni A; Kosoko TO; Agbeyangi O; Bankole S; Toé L; Mafiana CF; Yameogo L
    J Vector Borne Dis; 2012 Jun; 49(2):101-4. PubMed ID: 22898482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.
    Abanobi OC; Anosike JC
    Public Health; 2000 Sep; 114(5):402-6. PubMed ID: 11035465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
    Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
    Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endemicity of onchocerciasis in some local government areas of Niger state.
    Idowu ET; Adewale B; Mafe MA; Appelt B; Bamgbose A
    Afr J Med Med Sci; 2004 Mar; 33(1):31-4. PubMed ID: 15490791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
    Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
    Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
    Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
    Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei sl is the vector.
    Katabarwa M; Onapa AW; Nakileza B
    East Afr Med J; 1999 Aug; 76(8):440-6. PubMed ID: 10520349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities.
    Collins RC; Gonzales-Peralta C; Castro J; Zea-Flores G; Cupp MS; Richards FO; Cupp EW
    Am J Trop Med Hyg; 1992 Aug; 47(2):156-69. PubMed ID: 1503185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
    Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
    Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community response to repeated annual ivermectin treatment of onchocerciasis in Nigeria.
    Oyibo WA; Fagbenro-Beyioku AF
    Parasitol Res; 2002 Jul; 88(7):704-7. PubMed ID: 12107465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
    Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
    Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
    Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
    Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
    Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.